Experience in managing patients with Churg-Strauss syndrome.
DOI:
https://doi.org/10.26641/2307-0404.2018.1(part1).127252Keywords:
Churg-Strauss syndrome, diagnosis, treatmentAbstract
Our goal was to analyze the possibilities of improving the diagnostics of CSS and to improve the effectiveness of treatment according to the existing literature and our own experience of long-term care for patients with eosinophilic granulomatosis with polyangiitis or Churg-Strauss syndrome (CSS). The medical histories of three female patients aged 26 to 46-years and a 20-year-old male patient were considered. The duration of the disease before the established diagnosis was 5-17 years. Anamnesis and medical documents analysis showed a typical CSS debut in the form of allergic rhinitis, nasal polyps, which were recurrent after polypectomy, and respiratory disorders, which were regarded as bronchitis or bronchial asthma – corresponding to the first phase, also called the prodromal or allergic stage of CSS. The prodromal period lasts up to 10 years or more and is characterized by various allergic manifestations, more often – pollinosis or bronchial asthma, that is difficult to control. But CSS can be suspected because of low effectiveness of the therapy with inhaled steroids, lack of effect of antibiotics and eosinophilia more than 10% that occurs periodically. Even in the third stage of CSS in systemic manifestations of vasculitis and severe secondary lesions of organs and tissues with functional impairment, constant intake of maintenance doses of corticosteroids and cytostatics allows to achieve stabilization of the process in patients with CSS.
References
Beketova TV, Volkov MYu. [International recommendations for the diagnosis and treatment of eosinophilic granulomatosis with polyangiitis]. Nauchno-prakticheskaya revmatologiya. 2016;54(2):129-37. Russian.
Kovalenko VM,SHubaNM. [Nomenclature, classification, diagnostic criteria and treatment program for rheumatic diseases]. 2004;156. Ukrainian.
Kovalenko VM, SHuba NM, Gayko GV, Korzh MO, et al. [Nomenclature, classification, diagnostic criteria and treatment program for rheumatic diseases]. 2008;214. Ukrainian.
Knyaz’kova II. [The Churg-Strauss syndrome]. Klіnіch. іmunologіya. Alergologіya. Іnfektologіya. 2013;9/10:14-20. Ukrainian.
Lischuk-Yakimovich XO. ]Differential diagnosis of clinical course of bronchial asthma and Churg-Strauss syndrome on the background of eosinophilia]. Dosâgnennâ bìologìï ta medicini. 2013;2:64-67. Ukrainian.
Moiseyev SV, Semenkova EN, Novikov PI. [The current nomenclature of systemic vasculitis - the recommendations of the international consensus conference (Chapel Hill, 2012)]. Klinicheskaya nefrologiya. 2012;l(2):41-46. Russian.
CHop’yak VV, Lіshchuk-Yakimovich KO, Pukalyak RM. [Immunologicalrisksofthe Churg-Strauss syndrome in patients with bronchial asthma with eosinophilia]. Ukraïns′kij medičnij časopis. 2011;6:124-7. Ukrainian.
Churg J, Strauss L. Allergic granulomatosis, allergic angiitis, and periarteritisnodosa. Am J Pathol. 1951;27:277-94.
Masi AT, Hunder GG, Lie JT, et al. TheAmericanCollegeof Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheumatology. 1990;33:1094-100.
Watts RA, Scott DG. Epidemiology of vasculitis. In: L. Bridges, G. Ball (eds.) Vasculitis. 2nd ed. Oxford University Press, Oxford. 2008;2.
Downloads
How to Cite
Issue
Section
License
Copyright (c) 2018 Medicni perspektivi
This work is licensed under a Creative Commons Attribution 4.0 International License.
Submitting manuscript to the journal "Medicni perspektivi" the author(s) agree with transferring copyright from the author(s) to publisher (including photos, figures, tables, etc.) editor, reproducing materials of the manuscript in the journal, Internet, translation into other languages, export and import of the issue with the author’s article, spreading without limitation of their period of validity both on the territory of Ukraine and other countries. This and other mutual duties of the author and all co-authors separately and editorial board are secured by written agreement by special form to use the article, the sample of which is presented on the site.
Author signs a written agreement and sends it to Editorial Board simultaneously with submission of the manuscript.